Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 12/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 11/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.45 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.36 |
| ▸ | PIM1 | P11309 | 4/20 | 0.35 |
| ▸ | PIM3 | Q86V86 | 3/20 | 0.35 |
| ▸ | PIM2 | Q9P1W9 | 3/20 | 0.35 |
| ▸ | FLT3 | P36888 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.35 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3848468 | 0.95 | MCHR1 (0.42) | MCHR1ADRA2ANPY5RDDR1SLC6A4 | |
| SCHEMBL3848466 | 0.95 | MCHR1 (0.42) | MCHR1ADRA2ANPY5RDDR1SLC6A4 | |
| SCHEMBL13620375 | 0.94 | MCHR1 (0.46) | MCHR1ADRA2ANPY5RDDR1PRKCQ | |
| SCHEMBL13620269 | 0.92 | MCHR1 (0.46) | MCHR1ADRA2ANPY5RDDR1PRKCQ | |
| SCHEMBL13620258 | 0.92 | MCHR1 (0.46) | MCHR1ADRA2ANPY5RDDR1PRKCQ | |
| SCHEMBL13620032 | 0.92 | MCHR1 (0.46) | MCHR1ADRA2ANPY5RDDR1PRKCQ | |
| SCHEMBL13620044 | 0.92 | MCHR1 (0.46) | MCHR1ADRA2ANPY5RDDR1PRKCQ | |
| SCHEMBL13620188 | 0.92 | MCHR1 (0.46) | MCHR1ADRA2ANPY5RDDR1PRKCQ | |
| SCHEMBL13620287 | 0.91 | MCHR1 (0.42) | MCHR1ADRA2ANPY5RDDR1 | |
| SCHEMBL13620203 | 0.89 | MCHR1 (0.44) | MCHR1ADRA2ANPY5RDDR1PRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090281075-A1 | ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS | PHARMACOPEIA, INC. (US) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281075-A1 | ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS | PRKCE, PRKCZ, PRKCQ | MCHR1 3804/4885ADRA2A 461/4885NPY5R 3514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.